T1	Entity 114 152	post-squalene cholesterol biosynthesis
T2	Entity 170 201	mammalian embryonic development
T3	Entity 203 216	Neonatal mice
T4	KeyEntity 236 275	dehydrocholesterol Î”7-reductase (Dhcr7)
T5	Entity 310 336	Smith-Lemli-Opitz syndrome
T6	Entity 477 496	respiratory failure
T7	Entity 504 541	developmental pulmonary abnormalities
R1	participates_in Arg1:T7 Arg2:T6	
T8	Entity 605 627	cholesterol deficiency
T9	Entity 631 647	lung development
T10	KeyEntity 737 753	Dhcr7-/- embryos
T11	KeyEntity 859 875	Dhcr7-/- embryos
T12	KeyEntity 951 959	Dhcr7-/-
T13	Entity 994 1022	delayed saccular development
T14	Entity 1038 1058	all Dhcr7-/- embryos
T15	Entity 1088 1112	pre-alveolar development
T16	Entity 1144 1162	cell proliferation
T17	Entity 1172 1230	differentiation of type I alveolar epithelial cells (AECs)
T18	Entity 1243 1263	vascular development
T19	Entity 1300 1331	Differentiation of type II AECs
T20	Entity 1367 1396	surfactant protein (SP) mRNAs
T21	Entity 1401 1420	SP-C immunostaining
T22	Entity 1610 1630	sonic hedgehog (Shh)
T23	Entity 1736 1739	Shh
T24	Entity 1789 1805	Dhcr7-/- embryos
T25	Entity 1844 1866	cholesterol deficiency
T26	KeyEntity 1877 1882	Dhcr7
T27	Entity 1910 1943	distinct lung saccular hypoplasia
T28	Entity 1998 2011	alveolar sacs
T29	Entity 2042 2053	type I AECs
T30	Entity 2061 2086	immature vascular network
T31	Entity 2090 2113	late gestational stages
T32	Entity 2184 2215	sterol deficiency by Dhcr7 loss
T33	Entity 2286 2322	dysregulated Shh-Patched-Gli pathway
T34	Entity 0 32	Late gestational lung hypoplasia
T35	Entity 57 83	Smith-Lemli-Opitz syndrome
